Frank Reynolds

Biography

Frank invented the NeuroScaffold™, the first treatment to restore function in humans after a traumatic spinal cord injury. In 2014, Frank won a life-time achievement award for curing paralysis from the National Spinal Injury Association. Frank succeeds for obvious reasons, the proper core competencies. Called the “Steve Jobs” of Life Sciences by globally renowned scientists, Frank is the most inventive CEO in Pharma since 2005. He is a co-inventor on over 50 biomaterials based and neurologically focused patent applications. His research has been published in the Journal of Biomaterials and the Journal of Neuroscience: Methods. Mr. Reynolds was featured in the March 2010 and October 2009 issues of Inc. Magazine. He was awarded the 2010 Irish Life Science 50 Award by the President of Ireland, Mary McAleese. Mr. Reynolds won the American Spinal Injury Association’s “2011 David F Apple Award for Excellence in Publishing” in spinal cord injury rehabilitation research. Frank Reynolds co-founded PixarBio Corporation to invent, research and develop biologics, drugs, and devices for a range a neurological conditions. Since September 2013, pain, spinal cord injury, epilepsy, and Parkinson’s disease are a prime focus of his research. As a neuroscientist, engineer and entrepreneur Frank invents his own neurological products and he recruits the teams to commercialize his patents and trade secrets. Frank is the only CEO in Pharma with relevant education and optimized subject matter expertise and core competencies to succeed in the Neuro-Pharma industry. Frank’s competencies in neuroscience, spinal-cord neurosurgery, drug discovery, drug delivery, US FDA Regulatory Affairs, Clinical Studies, cGMP Manufacturing, Patents, Intellectual Property, GAAP, SEC, Financial Analysis, MIS, Serialization, HR, Process Engineering, all combined led to miraculous breakthrough for paralyzing spinal cord injury, the NeuroScaffold™. Frank won the IABCN 2015 “Taoiseach Award” or Prime Minister’s Award for Leadership, presented by Anne Anderson, Ireland Ambassador to the USA. Formal education at MIT, Harvard, Wharton, Univ. of Penn Engineering, St. Joseph’s, Temple University, Chestnut Hill College, Rider University and other universities provided Frank with perfect education to develop new treatments for neurological disease. Frank serves on the Board of Directors of Chestnut Hill College. Frank founded InVivo Therapeutics in 2005, and took the company public as InVivo Therapeutics Holdings Corporation (NVIV) in October 2010. Frank served as Chairman of the Board, CEO and CFO until his retirement in August 2013. Under his leadership, InVivo’s market cap reached $520M. Other awards: • PixarBio was awarded “2016 Best Places to Work in Boston” • Frank received the Irish Education 100 Award in 2013, 2014, 2015 • Mr. Reynolds was nominated for the “2013 Boston Business Journal CFO of the Year” • Reynolds led InVivo Therapeutics to win the Boston Business Journal’s “2013 Best Places to Work in Boston”. Relevant Corporate Governance • Executive Board Member of the Irish American Business Chamber • Board of the Special Olympics of Massachusetts (Ret) • Member of the American College of Healthcare Executives • Member of the American Psychological Association. • Chairman of the Board, InVivo Therapeutics Corp Frank has over 35 years of management experience and was the founder and CEO of Expand The Knowledge, Inc. an IT Consulting firm to the financial and pharma sector.

Research Interest

 neuroscience, spinal-cord neurosurgery, drug discovery